RxDoctor Payments Data

Alyssa Hagy

Psychiatric/Mental Health · Stroudsburg, PANPI 1649044629

Payments from drug & device makers

$2,668in general payments, 2019–2025

Across 146 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$474
  • Neurocrine Biosciences, Inc.$450
  • Johnson & Johnson$373
  • Alkermes, Inc.$242
  • AbbVie$210
  • Lundbeck LLC$205
  • plus $714 from 11 others

What the payments were for

  • Food & beverage$2,668100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,668 in reported general payments places this provider in the 80th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$9,248
Medicare patients
66
Services billed
137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide78$55,255
RexultiBrexpiprazole26$49,898
VraylarCariprazine Hcl20$32,581
Aripiprazole173$14,036
VyvanseLisdexamfetamine Dimesylate34$11,181
Duloxetine Hcl170$7,248
Paliperidone ErPaliperidone14$4,028
Lisdexamfetamine Dimesylate16$3,023
Ziprasidone Hcl70$2,922
Bupropion XlBupropion Hcl95$2,700
Quetiapine Fumarate155$2,622
Atomoxetine Hcl20$1,952
Trazodone Hcl227$1,939
Venlafaxine Hcl ErVenlafaxine Hcl77$1,810
Divalproex Sodium67$1,791

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$186$66,435112 claims
Otsuka America Pharmaceutical, Inc.Rexulti$155$49,89826 claims
AbbVieVraylar$210$32,58120 claims
Almatica Pharma LLCSertraline Hcl$16$685106 claims
Teva Pharmaceuticals USA, Inc.Loxapine$474$64012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

Other psychiatric/mental health in Stroudsburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →